Correlation of Serum Anti-Mullerian Hormone with Hormonal and Environmental Parameters in Brazilian Climacteric Women

Overview

Journal Sci Rep

Specialty Science

Date 2022 Jul 14

PMID 35835777

Authors

Thiago Magalhaes Gouvea

Laura Alves Cota E Souza

Angelica Alves Lima

Affiliations

Soon will be listed here.

Abstract

This study aimed to identify the correlation among anti-Mullerian Hormone serum levels and 25-OH-D, obesity, metabolic syndrome (MetS), and sexual hormones in climacteric women classified according to stages of reproductive aging (SRA). A cross-sectional study was conducted with a total of 177 Brazilian climacteric women between 40 and 64 years old. Concentrations of AMH were measured using the Access 2 Immunoassay System. A multiple linear regression analysis was used to identify the relationship among AMH, 25-OH-D, obesity, MetS, sexual hormones, sociodemographic and lifestyle factors. AMH levels decreased with increased age (B = - 0.059; p < 0.001), and reproductive aging (B = - 0.483; p < 0.001). Obesity indicators, lifestyle characters, 25-OH-D levels and MetS were not significantly associated with AMH serum concentration. Negative correlation was found for FSH (B = - 0.009; p < 0.001) and LH (B = - 0.006; p = 0.004); positive correlation for E2 (B = 0.001; p = 0.011), DHEAS (B = 0.003; p < 0.001) and SHBG (B = 0.003; p = 0.005). In the model adjusted for SRA, FSH levels (p < 0.001) and DHEAS (p = 0.014) were associated with AMH. Although, with the adjustment for age, only FSH remained with a significant association (p = 0.001). Of the other analytes, none was associated with AMH, regardless of the model fit. Our findings confirm that serum AMH level decreased with age and FSH levels, but there is no correlation between AMH with obesity, 25-OH-D, MetS or other sexual hormones in Brazilian climacteric women.

References

Durlinger A, Kramer P, Karels B, de Jong F, Uilenbroek J, Grootegoed J . Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999; 140(12):5789-96. DOI: 10.1210/endo.140.12.7204. View

La Marca A, Broekmans F, Volpe A, Fauser B, Macklon N . Anti-Mullerian hormone (AMH): what do we still need to know?. Hum Reprod. 2009; 24(9):2264-75. DOI: 10.1093/humrep/dep210. View

Broer S, Broekmans F, Laven J, Fauser B . Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014; 20(5):688-701. DOI: 10.1093/humupd/dmu020. View

Baarends W, Uilenbroek J, Kramer P, Hoogerbrugge J, van Leeuwen E, Themmen A . Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995; 136(11):4951-62. DOI: 10.1210/endo.136.11.7588229. View

Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate R, Skakkebaek N . Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 1999; 84(10):3836-44. DOI: 10.1210/jcem.84.10.6047. View

Durlinger A, Gruijters M, Kramer P, Karels B, Ingraham H, Nachtigal M . Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002; 143(3):1076-84. DOI: 10.1210/endo.143.3.8691. View

Durlinger A, Visser J, Themmen A . Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002; 124(5):601-9. DOI: 10.1530/rep.0.1240601. View

Feyereisen E, Lozano D, Taieb J, Hesters L, Frydman R, Fanchin R . Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online. 2006; 12(6):695-703. DOI: 10.1016/s1472-6483(10)61081-4. View

Richardson S, Senikas V, NELSON J . Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987; 65(6):1231-7. DOI: 10.1210/jcem-65-6-1231. View

10.

de Vet A, Laven J, de Jong F, Themmen A, Fauser B . Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002; 77(2):357-62. DOI: 10.1016/s0015-0282(01)02993-4. View

11.

Sowers M, Eyvazzadeh A, McConnell D, Yosef M, Jannausch M, Zhang D . Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008; 93(9):3478-83. PMC: 2567855. DOI: 10.1210/jc.2008-0567. View

12.

Seifer D, MacLaughlin D, Penzias A, Behrman H, Asmundson L, Donahoe P . Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content. J Clin Endocrinol Metab. 1993; 76(3):711-4. DOI: 10.1210/jcem.76.3.8445031. View

13.

Loh J, Maheshwari A . Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing?. Hum Reprod. 2011; 26(11):2925-32. DOI: 10.1093/humrep/der271. View

14.

Tran N, Cedars M, Rosen M . The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab. 2011; 96(12):3609-14. DOI: 10.1210/jc.2011-0368. View

15.

Soules M, Sherman S, Parrott E, Rebar R, Santoro N, Utian W . Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001; 76(5):874-8. DOI: 10.1016/s0015-0282(01)02909-0. View

16.

Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R . Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012; 15(2):105-14. PMC: 3580996. DOI: 10.3109/13697137.2011.650656. View

17.

Hale G, Robertson D, Burger H . The perimenopausal woman: endocrinology and management. J Steroid Biochem Mol Biol. 2013; 142:121-31. DOI: 10.1016/j.jsbmb.2013.08.015. View

18.

van Rooij I, Broekmans F, Te Velde E, Fauser B, Bancsi L, de Jong F . Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17(12):3065-71. DOI: 10.1093/humrep/17.12.3065. View

19.

Gruijters M, Visser J, Durlinger A, Themmen A . Anti-Müllerian hormone and its role in ovarian function. Mol Cell Endocrinol. 2003; 211(1-2):85-90. DOI: 10.1016/j.mce.2003.09.024. View

20.

La Marca A, De Leo V, Giulini S, Orvieto R, Malmusi S, Giannella L . Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig. 2005; 12(7):545-8. DOI: 10.1016/j.jsgi.2005.06.001. View